Brief: Medicamen Biotech Ltd Dec-Quarter Consol Net Profit Falls
10/02/2023 12:12
Feb 10 (Reuters) - Medicamen Biotech Ltd MEBI.NS :
* DEC-QUARTER CONSOL NET PROFIT 37.7 MILLION RUPEES VERSUS
37.8
MILLION RUPEES
* DEC-QUARTER CONSOL INCOME FROM OPERATIONS 355.8 MILLION
RUPEES
VERSUS 326.4 MILLION RUPEES
Source text for Eikon: ID:nBSEb5YTRs
Further company coverage: MEBI.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma